Zantac has been facing legal trouble since September 2019, when online pharmacy, Valisure, discovered “extremely high levels of N-Nitrososdimethylamine (NDMA)” in the popular heartburn medication. This discovery was notable for 2 reasons:
- NDMA is a probable human carcinogen – or a substance that could cause cancer.
- Valisure’s citizen petition launched a large-scale investigation by the U.S. Food & Drug Administration (FDA).
After months of testing and voluntary recalls, the FDA ultimately took Zantac off the market and encouraged consumers to throw away any pills, tablets, or liquids they might have.
By then, however, it was already too late for some consumers. Multiple lawsuits have emerged linking Zantac to cancers of the digestive system.
If you have taken Zantac for an extended period and suffered a cancer diagnosis, please contact Elizabeth A. Citrin, P.C. today.
What Is Zantac (Ranitidine)?
Zantac is an over the counter (OTC) and prescription heartburn medicine developed and sold by Sanofi. It was first introduced to the market in 1986 and by, 1988, Zantac became the first drug to surpass $1 billion in annual sales. Until 2019, Zantac and its generic versions were popular choices for preventing and treating heartburn. Prescription-strength Zantac is also used to prevent and treat ulcers in the stomach and intestines.
The active ingredient in Zantac is ranitidine, which is an H2 (histamine-2) blocker.
All ranitidine products have the potential to host unsafe levels of NDMA when stored over time and/or in warm environments.
So far, lawsuits have been filed against Sanofi, Pfizer, Boehringer Ingelheim, and GlaxoSmithKline.
To file a new claim or join a class-action lawsuit, please call us at (251) 202-3374.
What Is NDMA?
NDMA is an environmental contaminant found in food and water, especially dairy, vegetables, and grilled meats. In small doses, it usually doesn’t harm human health. Over time, however, NDMA can build up in the digestive tract and lead to various cancers. The FDA recommends humans limit their daily intake of NDMA to 0.096 micrograms or 0.32 parts per million (ppm), but Zantac and other ranitidine drugs had NDMA levels as high as 2.95 ppm and 0.86 micrograms per dose.
In many situations, the amount of NDMA in Zantac exceeds the FDA’s daily intake limits, putting consumers at a heightened risk of cancer.
If you have been diagnosed with cancer as a result of taking Zantac, Attorney Elizabeth A. Citrin can help.
What Your Next Steps Should Be
Per the FDA’s statement on April 1, 2020, safely dispose of any Zantac or ranitidine products you still have and do not buy more. If you are taking prescription Zantac, talk to your doctor about switching medications. So far, FDA testing has not found NDMA in Pepcid, Tagamet, Nexium, Prevacid, or Prilosec.
If you have taken Zantac weekly for at least 6 months or regularly for a year or more and developed any of the following diseases, please call our firm:
- Esophageal cancer
- Stomach cancer
- Pancreatic cancer
- Bladder cancer
- Liver cancer
Remember, Zantac has been on the market since 1986, but the link between the popular heartburn drug and cancer only became clear in September 2019. If you have questions about your diagnosis, do not hesitate to…
Contact Elizabeth A. Citrin, P.C. Today
The legal process can be overwhelming, but Elizabeth A. Citrin will make sure you feel supported and comfortable every step of the way. We will take care of your case, so you can focus on getting better.
Additionally, our firm has a history of both satisfied clients and real results. For the personal attention you need to feel at ease and the experiences and resources you need to win, contact Elizabeth A. Citrin, P.C. today.
We are available to answer your questions 24/7. Call us at (251) 202-3374 to get started!
Contact Our Firm
"I focus on the legal issues, while you focus on what is most important—you!"